Internal Medicine, Clinical Cardiatric Electrophysiology · Tallahassee, FL
NPI
1598752412
Since 2005
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2100 Centerville Rd
Tallahassee, FL, 32308
Phone (850) 216-0178
Groups this clinician bills Medicare through
Medicare paid, 2024
$223K
4,093 services
Medicare patients, 2024
1,009
Average age 78
Drug cost, 2024
$3.6M
10,716 prescriptions
Company payments, 2025
$599
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gad A Silberman was code 93294 (external electrocardiographic monitoring), 721 times for 244 patients. In total Gad A Silberman billed 4,093 services in 92 codes, and Medicare paid $223K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93294 External Electrocardiographic Monitoring | Office | 721 | 244 | $22.63 | $16K |
| 93298 External Electrocardiographic Monitoring | Office | 477 | 82 | $21.55 | $10K |
| 93000 Electrocardiogram | Office | 430 | 345 | $10.54 | $4,532 |
| 93010 Electrocardiogram | Facility | 413 | 312 | $6.65 | $2,747 |
| 99233 Hospital E&M - Subsequent | Facility | 245 | 103 | $99.18 | $24K |
| 99214 Office E&M - Established | Office | 209 | 198 | $88.34 | $18K |
| 93295 External Electrocardiographic Monitoring | Office | 174 | 60 | $26.56 | $4,621 |
| 99215 Office E&M - Established | Office | 161 | 135 | $132.67 | $21K |
| 93280 External Electrocardiographic Monitoring | Office | 121 | 104 | $58.85 | $7,121 |
| 93306 Echocardiography (TTE/TEE) | Office | 96 | 95 | $144.23 | $14K |
| 99223 Hospital E&M - Initial | Facility | 95 | 94 | $140.60 | $13K |
| 93306 Echocardiography (TTE/TEE) | Facility | 60 | 60 | $56.66 | $3,399 |
| 99205 Office E&M - New | Office | 55 | 55 | $171.07 | $9,409 |
| 93228 Electrocardiogram | Office | 47 | 44 | $19.86 | $934 |
| 36415 Venipuncture Blood Collection | Office | 43 | 32 | $8.65 | $372 |
By year: 2022 $243K for 4,396 services; 2023 $240K for 4,866 services; 2024 $223K for 4,093 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 43 | 32 | $8.65 | $372 |
Medicare prescription drug claims, 2024
In 2024, the drug Gad A Silberman prescribed most often to Medicare patients was Eliquis (Apixaban), with 3,713 prescriptions and refills. In total Gad A Silberman wrote 10,716 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 3,713 | 4,852 | 564 | $2.7M |
| Metoprolol Succinate Generic | 2,203 | 4,318 | 526 | $46K |
| Dofetilide Generic | 395 | 642 | 72 | $89K |
| Carvedilol Generic | 390 | 816 | 93 | $3,962 |
| Xarelto Rivaroxaban | 370 | 586 | 70 | $312K |
| Amlodipine Besylate Generic | 331 | 690 | 93 | $2,831 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 320 | 630 | 76 | $9,672 |
| Amiodarone Hcl Generic | 279 | 535 | 78 | $3,851 |
| Losartan Potassium Generic | 242 | 493 | 63 | $2,663 |
| Jardiance Empagliflozin | 207 | 269 | 42 | $151K |
| Sotalol Sotalol Hcl | 172 | 325 | 39 | $3,979 |
| Lisinopril Generic | 164 | 347 | 42 | $1,216 |
| Entresto Sacubitril/Valsartan | 131 | 170 | 18 | $112K |
| Dabigatran Etexilate Dabigatran Etexilate Mesylate | 130 | 150 | 62 | $13K |
| Potassium Chloride Generic | 123 | 205 | 34 | $1,740 |
Brand drugs: 4,552 claims; generic drugs: 6,164 claims; opioid claims: 61.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gad A Silberman $599 ($599 in general payments such as food, travel and fees) from 8 companies. The largest payer was Medtronic, Inc. with $212.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.